Tecan Group AG (TCHBF)
OTCMKTS
· Delayed Price · Currency is USD
214.44
-4.35 (-1.99%)
At close: Feb 21, 2025
Tecan Group AG Revenue
In the year 2024, Tecan Group AG had annual revenue of 934.28M CHF, down -13.04%. Tecan Group AG had revenue of 467.16M in the half year ending June 30, 2024, a decrease of -20.01%.
Revenue
934.28M CHF
Revenue Growth
-13.04%
P/S Ratio
n/a
Revenue / Employee
261.48K CHF
Employees
3,573
Market Cap
2.70B USD
Revenue Chart
* This company reports financials in CHF.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 934.28M | -140.11M | -13.04% |
| Dec 31, 2023 | 1.07B | -69.88M | -6.11% |
| Dec 31, 2022 | 1.14B | 197.64M | 20.88% |
| Dec 31, 2021 | 946.62M | 215.74M | 29.52% |
| Dec 31, 2020 | 730.88M | 94.06M | 14.77% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.79B |
| SS Innovations International | 16.04M |
| Veradigm | 1.53B |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 188.29M |
| Northwest Biotherapeutics | 1.60M |
| Silence Therapeutics | 43.26M |
| BioStem Technologies | 210.49M |
Tecan Group AG News
- 7 months ago - Tecan Group AG (TCHBF) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Tecan Group AG (TCHBF) Q4 2023 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Tecan Group AG (TCHBF) Q2 2023 Earnings Call Transcript - Seeking Alpha
- 2 years ago - Tecan Group AG (TCHBF) Q4 2022 Earnings Call Transcript - Seeking Alpha